Ventricular tachycardia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ventricular tachycardia}}
{{Ventricular tachycardia}}
{{CMG}}; '''Associate Editor-in Chief''': [[User:Avirupguha|Avirup Guha, M.B.B.S.]][mailto:avirup.guha@gmail.com]
{{CMG}}; '''Associate Editor-in Chief''':{{Sara.Zand}} [[User:Avirupguha|Avirup Guha, M.B.B.S.]][mailto:avirup.guha@gmail.com]
==Overview==
==Overview==
[[Ischemic heart disease]] is the most common cause of [[ventricular tachycardia]]. [[VT]] causes approximately half of the 300,000 [[sudden deaths]] which occur out of hospital annually in the US. [[Brugada syndrome]] is thought to be the cause of half of the [[sudden cardiac deaths]] which occurs in young individuals without [[structural heart disease]].
[[VT]] is more prevalent among [[patients]] with [[coronary artery disease]]. Eldery [[patients]] are more commonly affected by ideopathic [[VT]]. Ideopathic [[VT]] is commonly observed in [[women]].There is no racial predilection for [[VT]].


==Epidemiology ==
==Epidemiology ==

Latest revision as of 07:35, 29 May 2021

Ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ventricular Tachycardia from other Disorders

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac MRI

Other Diagnostic Tests

Treatment

Medical Therapy

Electrical Cardioversion

Ablation

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ventricular tachycardia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ventricular tachycardia epidemiology and demographics

CDC onVentricular tachycardia epidemiology and demographics

Ventricular tachycardia epidemiology and demographics in the news

Blogs on Ventricular tachycardia epidemiology and demographics

to Hospitals Treating Ventricular tachycardia epidemiology and demographics

Risk calculators and risk factors for Ventricular tachycardia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in Chief:Sara Zand, M.D.[2] Avirup Guha, M.B.B.S.[3]

Overview

VT is more prevalent among patients with coronary artery disease. Eldery patients are more commonly affected by ideopathic VT. Ideopathic VT is commonly observed in women.There is no racial predilection for VT.

Epidemiology

Age

Gender

Race

References

  1. Aronow, W. S.; Ahn, C.; Mercando, A. D.; Epstein, S.; Kronzon, I. (2002). "Prevalence and Association of Ventricular Tachycardia and Complex Ventricular Arrhythmias With New Coronary Events in Older Men and Women With and Without Cardiovascular Disease". The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 57 (3): M178–M180. doi:10.1093/gerona/57.3.M178. ISSN 1079-5006.
  2. 2.0 2.1 Sirichand, Surksha; Killu, Ammar M.; Padmanabhan, Deepak; Hodge, David O.; Chamberlain, Alanna M.; Brady, Peter A.; Kapa, Suraj; Noseworthy, Peter A.; Packer, Douglas L.; Munger, Thomas M.; Gersh, Bernard J.; McLeod, Christopher J.; Shen, Win-Kuang; Cha, Yong-Mei; Asirvatham, Samuel J.; Friedman, Paul A.; Mulpuru, Siva K. (2017). "Incidence of Idiopathic Ventricular Arrhythmias". Circulation: Arrhythmia and Electrophysiology. 10 (2). doi:10.1161/CIRCEP.116.004662. ISSN 1941-3149.


Template:WikiDoc Sources